Material and methods for treating developmental disorders including comorbid and idiopathic autism
AssigneeIndiana University Research and Technology Corporation
InventorCraig A. Erickson
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a method of treating a subject with autism spectrum disorder by administering an acetylaminopropane sulfonate. The acetylaminopropane sulfonate may have the following formula
Claims23
A method of treating a subject having an autism spectrum disorder, comprising the step of administering to the subject a therapeutically effective amount of a composition comprising an acetylaminopropane sulfonate or an acetylaminopropane sulfonate salt.
A method of treating a subject having fragile X syndrome, comprising the step of administering to the subject a therapeutically effective amount of a composition comprising an acetylaminopropane sulfonate or an acetylaminopropane sulfonate salt.
A method of treating a human having fragile X syndrome, comprising the step of administering to the human a therapeutically effective amount of a composition that includes Formula I:
- wherein the composition is administered two times a day or three times a day.
A method of treating a human having an autism spectrum disorder, comprising the step of administering to the human a therapeutically effective amount of a composition that includes Formula I:
- wherein the composition is administered two times a day or three times a day.
Dependencies are inferred from the claim text.